OakChart

Butterfly Network Inc

BFLYHealthcare·Medical Devices·USA·Small·NYSE·Nov 11 • 8:17 AM ET

6.84+0.33 (5.07%)
2026-11-11 14:22 CET
Market cap
1,741.18 USD m
Revenue, TTM
123.25 USD m
Net income, TTM
-53.69 USD m
Free cash flow, TTM
-27.55 USD m
EPS diluted, TTM
-0.21
P/E
-
Compare

Price

BFLY against its 20, 50 and 200-day averages
2050200beat
4.006.008.0010.0030.2M60.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BFLYclose 6.8420-day 6.9050-day 7.71200-day 6.136.84

33.0% under 10.21 on 6 Oct 2026. Last 15 sessions, 35.4% high to low

Profile

BFLY
52-week range, 59% of the way up
1.9010.21

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

IndexRUT
Employees220
IPOJul 13, 2020
Beta2.12
ATR, 14d0.56
Rel volume0.03
Short float15.78%
Insider own18.80%
Inst own64.98%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.83B
Enterprise Value1.73B
Income-53.69M
Sales123.25M
Book/sh0.69
Cash/sh0.46
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees220
IPOJul 13, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S14.84
P/B9.91
P/C14.96
P/FCF-
EV/EBITDA-
EV/Sales14.00
Quick Ratio2.66
Current Ratio3.58
Debt/Eq0.10
LT Debt/Eq0.08
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.21
EPS next Y-0.06
EPS next Q-0.02
EPS this Y47.22%
EPS next Y0.75%
EPS next 5Y-
EPS past 3/5Y28.25% 58.99%
Sales past 3/5Y9.97% 16.11%
EPS Y/Y TTM38.09%
Sales Y/Y TTM39.35%
EPS Q/Q64.32%
Sales Q/Q51.70%
EarningsOct 29 BMO
EPS/Sales Surpr.71.67% 14.91%

Ownership

Insider Own18.80%
Insider Trans-20.99%
Inst Own64.98%
Inst Trans18.01%
ROA-18.58%
ROE-27.65%
ROIC-26.84%
Gross Margin70.26%
Oper. Margin-36.09%
Profit Margin-43.56%
SMA20-0.92%
SMA50-11.33%
SMA20011.65%
Trades-

Technical

Shs Outstand245.91M
Shs Float217.19M
Short Float15.78%
Short Ratio6.73
Short Interest34.27M
52W High10.21 -33.01%
52W Low1.90 260.00%
Volatility8.19% 7.66%
ATR (14)0.56
RSI (14)46.77
Beta2.12
Rel Volume0.03
Avg Volume5.09M
Volume6,960

Performance

Perf Week1.03%
Perf Month-15.56%
Perf Quarter-22.80%
Perf Half Y74.49%
Perf YTD80.00%
Perf Year178.05%
Perf 3Y539.25%
Perf 5Y-24.92%
Perf 10Y-
Recom1.00
Target Price11.00
Prev Close6.51
Price6.84
Change %5.07%

Analyst ratings

latest 10 of 12
DateActionAnalystRating changeTargetImplied
Oct 12, 2026InitiatedCCanaccord GenuityBuy$10+46.2%
Sep 29, 2026InitiatedEEvercore ISIOutperform$15+119.3%
Sep 22, 2026InitiatedNNeedhamBuy$10+46.2%
Aug 01, 2025DowngradeOOppenheimerOutperform → Perform
Jul 01, 2025InitiatedCCraig HallumBuy$3-56.1%
Mar 17, 2025InitiatedWWilliam BlairOutperform
Sep 10, 2024InitiatedLLake StreetBuy$3-56.1%
Mar 29, 2023InitiatedUUBSNeutral$2.25-67.1%
Nov 29, 2022InitiatedOOppenheimerOutperform$4.50-34.2%
Oct 04, 2022InitiatedRB. Riley SecuritiesBuy$9.50+38.9%

Peers

Mkt cap
TickerCompanyMkt cap
GEHCGE HealthCare Technologies Inc37.55B
PHGKoninklijke Philips NV ADR29.11B
HYPRHyperfine Inc72.12M
NNOXNano X Imaging Ltd30.86M
IRTCiRhythm Holdings Inc3.00B
IRMDIradimed Corp1.11B
HTFLHeartflow Inc4.85B
TEMTempus AI Inc15.14B
LNTHLantheus Holdings Inc6.64B
TDOCTeladoc Health Inc1.64B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
DEVIVO JOSEPHPresident & CEOOct 30 '26Sale7.0190,600634,9257,221,330Nov 03 04:40 PM
Joseph DeVivoPresident and CEOOct 30 '26Proposed Sale7.0090,600634,200Oct 30 04:21 PM
DEVIVO JOSEPHPresident & CEOOct 06 '26Sale10.0235,790358,6167,311,930Oct 08 05:55 PM
Carlson MeganCAO and SVP, FinanceOct 02 '26Sale8.7410,11488,447401,971Oct 06 04:36 PM
DEVIVO JOSEPHOfficerOct 06 '26Proposed Sale10.0235,790358,615Oct 06 02:39 PM
Carlson MeganOfficerOct 02 '26Proposed Sale8.7510,11488,448Oct 02 04:54 PM
DEVIVO JOSEPHPresident & CEOSep 23 '26Sale10.023,16931,7577,347,720Sep 24 05:50 PM
DEVIVO JOSEPHPresident & CEOSep 22 '26Sale10.002,81128,1107,350,889Sep 24 05:50 PM
DEVIVO JOSEPHOfficerSep 23 '26Proposed Sale10.023,16931,757Sep 23 04:32 PM
Schwartz EricaFormer DirectorSep 23 '26Proposed Sale10.00323,0203,230,200Sep 23 11:01 AM
DEVIVO JOSEPHOfficerSep 22 '26Proposed Sale10.002,81128,110Sep 22 05:00 PM
Schwartz EricaFormer DirectorSep 22 '26Proposed Sale10.0078,679786,790Sep 22 04:51 PM
Cashman SteveChief Business OfficerSep 04 '26Sale7.30140,1121,023,0981,490,295Sep 09 04:45 PM
Carlson MeganCAO and SVP, FinanceSep 04 '26Sale7.3013,804100,797412,085Sep 09 04:42 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
IWMiShares Russell 2000 Index FundAUM: 78.30B
ARKGARK Genomic Revolution ETFAUM: 2.07B
VXFVanguard Extended Market Index ETFAUM: 30.61B
IWOiShares Russell 2000 Growth ETFAUM: 14.20B
VTWOVanguard Russell 2000 Index ETFAUM: 16.97B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.85B
SCHASchwab U.S. Small-Cap ETFAUM: 22.32B
IHIiShares U.S. Medical Devices ETFAUM: 4.11B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.36B

News

latest 14 of 206
  • Butterfly Network Beats And Raises Again, But Its Record Quarter Rests Heavily On Embedded Licensing While The Core Business Grows Slowly (Earnings Whispers)
  • Butterfly Network Reports Third Quarter 2026 Financial Results (Business Wire)
  • Butterfly Network to Present at UBS Global Healthcare Conference on November 10, 2026 (Business Wire) +10.81%
  • Butterfly Network Faces A Lumpy Embedded Quarter As Core Ultrasound Must Prove It Can Carry Weight (Earnings Whispers)
  • The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound Education (Business Wire) -5.26%
  • Loading…
  • Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026 (Business Wire)
  • Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface (Business Wire) -7.25%
  • Butterfly Network Appoints Mike Noonen to Board of Directors (Business Wire)
  • Mendaeras Focalist System Now Compatible with Butterflys Ultrasound-on-Chip Technology (Business Wire)
  • Butterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026 (Business Wire)
  • Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces (Business Wire)
  • Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director (Business Wire)
  • Butterfly Network CEO Joe DeVivo Reveals What Fueled Firms 39% Annual Growth (NYSE) -12.97%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.010-0.035-0.05032.6028.376
2026Q22026-07-30-0.010-0.035-0.04932.6129.164
2026Q12026-04-30-0.030-0.049-0.04926.5326.083
2025Q42026-02-26-0.020-0.045-0.06131.5125.924
2025Q32025-10-31-0.040-0.043-0.13521.4921.223
2025Q22025-08-01-0.030-0.050-0.05623.3823.724
2025Q12025-05-02-0.040-0.070-0.05921.2321.164
2024Q42025-02-28-0.050-0.080-0.08522.3521.973
2024Q32024-11-01-0.050-0.077-0.08020.5618.953
2024Q22024-08-01-0.074-0.100-0.07421.4919.582
2024Q12024-05-01-0.070-0.120-0.10417.6616.802
2023Q42024-02-28-0.210-0.135-0.21316.5215.342
2023Q32023-11-02-0.130-0.149-0.13215.4215.134
2023Q22023-08-03-0.140-0.161-0.14018.4918.014
2023Q12023-05-11-0.170-0.206-0.16615.4815.803
2022Q42023-02-28-0.170-0.217-0.16818.9819.933

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-0.190-0.365-0.18762.5760.54
2022FY-0.840-0.887-0.84473.3974.33
2023FY-0.650-0.575-0.65165.9064.68
2024FY-0.210-0.310-0.34382.0681.67
2025FY-0.120-0.169-0.31097.6191.82
2026FY--0.063--124.86
2027FY--0.063--149.34
2028FY-0.007--195.97
2029FY--0.020--275.18
2030FY-0.315--422.19

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2981533.7132.5035.20
2026Q4S2026-10-2870034.0633.8034.70
2026Q4S2026-10-2170034.0733.8034.70
2026Q4S2026-10-1570134.0733.8034.70
2026Q4S2026-10-1370134.0633.8034.70
2026Q4S2026-10-0970434.0633.8034.70
2026Q4S2026-10-0660434.0733.8034.70
2026Q4S2026-09-2160434.0733.8034.70
2026Q4S2026-08-0750434.1333.8034.70
2026Q4S2026-07-3050334.2933.8034.80
2026Q4S2026-07-1450034.8434.7035.10
2026Q4S2026-06-1752034.8434.7035.10
2026Q4S2026-06-0452034.8434.7035.10
2026Q4S2026-05-1352034.8434.7035.10

Estimate history

EPS, annual-26.871-0.187-0.844-0.651-0.343-0.312-0.2072
Period202020212022202320242025TTM
EPS, quarterly-0.08-0.085-0.059-0.056-0.135-0.061-0.049-0.049-0.048
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual46.25262.56573.3965.982.05697.61123.25
Period202020212022202320242025TTM
Sales, quarterly20.56122.35121.22523.38321.48931.51426.5332.61232.598
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual6.593198.04200.887207.649215.053253.745267.332
Period202020212022202320242025MRQ
Shares, quarterly212.984215.053247.246251.037252.534253.745261.204264.422267.332
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue123.2597.6182.0665.9073.3962.5646.25
Cost of Goods Sold Incl. D&A36.6651.8833.2349.0433.9347.06108.65
Gross Profit86.6045.7348.8316.8639.4615.50-62.40
Selling, General and Administrative Excl. Other131.08121.37119.18142.50230.69202.8399.22
Research and Development39.5736.2637.8055.6288.0974.4649.74
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-44.48-75.64-70.35-125.65-191.23-187.33-161.62
Interest Expense1.241.491.260.000.000.651.14
Unusual Expense12.318.505.9215.42-19.07-155.700.00
Net Income Before Taxes-53.62-76.95-72.52-133.62-168.68-32.29-162.71
Income Taxes0.070.11-0.030.080.040.120.04
Consolidated Net Income-53.69-77.06-72.49-133.70-168.72-32.41-162.75
Net Income From Continuing Operations-53.69-77.06-72.49-133.70-168.72-32.41-162.75
Net Income-53.69-77.06-72.49-133.70-168.72-32.41-162.75
EPS (Recurring)-0.17-0.29-0.32-0.60-0.91-0.81-26.87
EPS (Basic, Before Extraordinaries)-0.21-0.31-0.34-0.65-0.84-0.19-26.87
EPS (Diluted)-0.21-0.31-0.34-0.65-0.84-0.19-26.87
EBITDA-37.64-67.56-60.00-116.87-185.29-185.24-160.30
Non-Operating Income (Expense)4.418.685.017.453.48-0.000.05
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense24.5123.4316.6221.7133.6034.8911.00
Price To Sales Ratio19.379.628.053.376.7018.592.59
Gross Margin70.2646.8559.5125.5853.7724.77-134.91
Operating Margin-36.09-77.49-85.73-190.66-260.57-299.42-349.43
Net Margin-43.56-78.95-88.34-202.88-229.90-51.80-351.87
Shares Outstanding267.33253.75215.05207.65200.89198.046.59
Market Capitalization1,741.181,741.18664.75223.69493.391,142.851,024.13

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue32.6032.6126.5331.5121.4923.3821.2322.35
Cost of Goods Sold Incl. D&A8.809.328.2410.2925.258.497.848.62
Gross Profit23.8023.2918.2921.22-3.7614.8913.3813.73
Selling, General and Administrative Excl. Other33.3433.3631.7732.6128.6229.0031.1430.62
Research and Development10.1710.549.549.328.708.319.928.83
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-9.53-10.08-13.49-11.39-32.38-14.11-17.76-16.89
Interest Expense0.280.280.280.390.390.370.350.33
Unusual Expense4.043.59-0.034.712.551.37-0.121.46
Net Income Before Taxes-12.81-12.91-12.68-15.23-33.95-13.81-13.96-18.21
Income Taxes0.000.000.000.070.020.020.01-0.11
Consolidated Net Income-12.81-12.91-12.68-15.29-33.97-13.83-13.97-18.10
Net Income From Continuing Operations-12.81-12.91-12.68-15.29-33.97-13.83-13.97-18.10
Net Income-12.81-12.91-12.68-15.29-33.97-13.83-13.97-18.10
EPS (Recurring)-0.04-0.04-0.05-0.05-0.13-0.05-0.06-0.08
EPS (Basic, Before Extraordinaries)-0.05-0.05-0.05-0.06-0.13-0.06-0.06-0.08
EPS (Diluted)-0.05-0.05-0.05-0.06-0.13-0.06-0.06-0.08
EBITDA-7.92-8.42-11.68-9.63-30.49-12.03-15.40-14.38
Non-Operating Income (Expense)1.061.041.061.251.362.034.030.47
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.737.044.386.363.894.634.964.14
Price To Sales Ratio19.3719.6810.079.845.505.686.268.11
Gross Margin73.0271.4168.9267.34-17.4863.6863.0461.45
Operating Margin-29.25-30.90-50.84-36.13-150.66-60.36-83.69-75.56
Net Margin-39.29-39.59-47.78-48.52-158.09-59.16-65.80-80.99
Shares Outstanding267.33264.42261.20253.75252.53251.04247.25215.05
Market Capitalization1,741.182,199.891,028.72959.89485.86494.58553.86664.75

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments150.4988.78134.64238.06422.8460.21
Short Term Receivables26.7420.7913.4214.6911.945.75
Inventories63.4576.3475.8495.1563.7428.38
Other Current Assets8.426.717.379.2413.383.00
Total Current Assets249.10192.61231.26357.14511.9097.33
Net Property, Plant & Equipment29.2433.7541.0052.9038.796.87
Total Investments and Advances4.014.014.014.014.000.00
Intangible Assets7.528.9210.32--0.00
Other Assets6.6616.7917.683.5217.2742.99
Total Assets296.53256.08304.27417.57571.97147.19
Short Term Debt Incl. Current Port. of LT Debt2.682.442.191.931.390.00
Accounts Payable5.444.255.097.215.8016.40
Income Tax Payable-----0.01
Other Current Liabilities57.0041.5336.9942.1942.6453.30
Total Current Liabilities65.1248.2244.2751.3349.8369.69
Long Term Debt17.7220.4022.8429.9727.6953.89
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities17.7218.6417.1110.9146.7624.60
Total Liabilities100.5587.2584.2292.21124.27148.19
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00360.94
Common Equity195.98168.83220.05325.36447.69-361.93
Total Shareholders Equity195.98168.83220.05325.36447.69-0.99
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity195.98168.83220.05325.36447.69-0.99
Total Liabilities & Stockholders Equity296.53256.08304.27417.57571.97147.19
Book Value Per Share0.770.791.061.622.26-54.89
Tangible Book Value Per Share0.740.741.011.622.26-54.89
Full-Time Employees220190225330463260
Price to Book Ratio9.443.650.871.442.963.92
Return on Assets-27.89-25.87-37.04-34.10-6.57-
Return on Equity-42.25-37.28-49.03-43.65-9.14-
Return on Invested Capital-36.06-38.31-55.05-47.48-6.82-307.65
Quick Ratio2.852.413.515.108.990.99
Current Ratio3.833.995.226.9610.271.40

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-53.69-77.06-72.49-133.70-168.72-32.41-162.75
Depreciation6.848.0810.348.775.932.091.32
Other Funds (Non Cash)27.7541.0525.2646.2423.07-107.8730.23
Funds from Operations-19.10-27.93-36.89-78.69-139.72-138.19-131.20
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-4.3015.23-4.82-20.13-29.40-51.0548.03
Income Taxes Payable------0.01
Cash from Operating Activities-23.40-12.70-41.71-98.82-169.12-189.24-83.17
Capital Expenditures-4.15-3.35-2.69-5.78-18.30-7.88-2.38
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.040.010.060.000.00
Purchase or Sale of Investments0.000.000.0076.19-75.53-1.990.00
Purchase of Investments0.000.000.00-0.30-75.53-1,019.000.00
Sale Or Maturity of Investments0.000.000.0076.480.001,017.010.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities-4.15-3.35-2.6670.41-93.78-9.87-2.38
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock87.9281.820.060.232.9821.712.04
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock87.9281.820.060.232.9821.712.04
Proceedsfrom Stock Options80.0681.010.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-4.3754.37
Change in Long Term Debt0.000.000.000.000.00-4.3754.37
Issuance of Long Term Debt0.000.000.000.000.000.0054.37
Reduction of Long Term Debt0.000.000.000.000.00-4.370.00
Net Financing Active Other Cash Flow-82.30-4.06-1.560.00-0.10548.40-0.66
Other Financing Activities Uses-2.71-5.47-2.050.00-0.100.00-0.66
Cash from Financing Activities5.6277.76-1.500.232.88565.7455.75
Net Change in Cash-21.9361.71-45.86-28.18-260.01366.63-29.80
Free Cash Flow-27.55-16.05-44.40-104.60-187.42-197.12-85.54
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments122.30124.66137.95150.49144.23148.14
Short Term Receivables37.3834.5525.2126.7424.4224.53
Inventories62.5160.7262.2163.4564.8873.46
Other Current Assets21.4818.0214.418.427.867.62
Total Current Assets243.67237.95239.79249.10241.39253.75
Net Property, Plant & Equipment27.2227.6628.3529.2429.9130.79
Total Investments and Advances4.014.014.014.014.014.01
Intangible Assets6.476.827.177.527.878.22
Other Assets6.616.566.616.666.8216.51
Total Assets287.98283.00285.92296.53290.00313.28
Short Term Debt Incl. Current Port. of LT Debt2.872.802.742.682.622.56
Accounts Payable5.663.522.825.443.313.32
Other Current Liabilities59.4652.2854.0257.0044.4138.79
Total Current Liabilities67.9958.6059.5865.1250.3344.67
Long Term Debt15.5516.2917.0217.7218.4119.10
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities20.0018.7018.1017.7217.4316.71
Total Liabilities103.5393.5994.70100.5586.1780.47
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity184.44189.40191.22195.98203.83232.81
Total Shareholders Equity184.44189.40191.22195.98203.83232.81
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity184.44189.40191.22195.98203.83232.81
Total Liabilities & Stockholders Equity287.98283.00285.92296.53290.00313.28
Book Value Per Share0.690.720.730.770.810.93
Tangible Book Value Per Share0.670.690.700.740.780.89
Full-Time Employees---220--
Price to Book Ratio9.4411.505.234.712.082.06
Return on Assets-18.58-25.11-25.08-27.89-28.77-21.43
Return on Equity-27.65-35.46-35.17-42.25-41.42-29.42
Return on Invested Capital-6.40-6.28-6.09-7.16-15.29-5.49
Quick Ratio2.663.022.982.853.514.04
Current Ratio3.584.064.023.834.805.68

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-12.81-12.91-12.68-15.29-33.97-13.83
Depreciation1.611.661.811.751.892.08
Other Funds (Non Cash)7.568.025.556.6322.775.74
Funds from Operations-3.64-3.23-5.32-6.91-9.32-6.01
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.37-13.04-8.5715.946.43-1.16
Cash from Operating Activities-2.27-16.27-13.899.03-2.89-7.17
Capital Expenditures-1.15-0.97-0.95-1.08-1.02-0.90
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.15-0.97-0.95-1.08-1.02-0.90
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1.053.962.3180.600.001.09
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1.053.962.3180.600.001.09
Proceedsfrom Stock Options0.000.000.0080.060.000.95
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-0.010.00-82.290.00-0.10
Other Financing Activities Uses0.00-0.010.00-2.700.000.00
Cash from Financing Activities1.053.952.31-1.690.000.99
Net Change in Cash-2.36-13.29-12.546.26-3.90-7.08
Free Cash Flow-3.41-17.24-14.847.95-3.90-8.06

Revenue breakdown

Product2024: 54.20M 2025: 63.44M
Software And Other Services2024: 27.86M 2025: 34.17M
Non-US2024: 18.63M 2025: 20.17M
United States2024: 63.42M 2025: 77.44M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.78%34.3M217.2M5.53M
2026-10-1515.54%33.6M216.2M5.95M
2026-09-3014.64%31.6M216.1M6.46M
2026-09-1516.53%35.7M216.1M8.10M
2026-08-3115.86%34.1M214.8M8.28M
2026-08-1415.00%32.2M214.5M8.25M
2026-07-3115.28%32.7M214.0M7.91M
2026-07-1515.41%31.3M202.8M7.77M
2026-06-3013.88%28.7M207.1M6.88M
2026-06-1512.45%25.9M207.7M4.89M
2026-05-2913.15%27.2M206.5M4.77M
2026-05-1512.50%25.0M199.8M5.87M
2026-04-3012.09%24.1M199.8M5.91M
2026-04-1512.92%25.0M193.9M5.63M
2026-03-3112.86%25.1M195.0M6.09M
2026-03-1313.29%25.9M195.0M6.24M
2026-02-2715.18%29.6M195.0M6.10M
2026-02-1312.89%24.9M193.2M5.61M
2026-01-3012.03%23.2M193.2M6.24M
2026-01-1513.81%26.7M193.2M5.99M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.005.306.000.0014.4880.000.000.981-0.0200.000
call2.503.804.505.147.1335.000.000.958-0.0200.001
call4.002.152.952.804.02110.000.000.926-0.0190.002
call5.001.351.701.641.8621,4631730.885-0.0160.002
call6.000.600.900.651.48812013.000.715-0.0200.004
call7.500.050.250.101.0792,4871100.240-0.0180.003
call9.000.000.100.031.5821,5185.000.131-0.0180.002
call10.000.000.250.041.6327,78111.000.071-0.0120.001
call11.000.000.050.071.90272.000.000.064-0.0130.001
call12.500.000.250.052.2391,8681.000.056-0.0140.001
call14.000.000.250.052.5345.000.000.051-0.0140.001
call15.000.000.150.052.8576820.000.081-0.0230.002
call17.500.000.050.052.86759.000.000.044-0.0140.001
put1.000.000.250.008.0120.000.00-0.019-0.0200.000
put2.500.000.250.114.1964.000.00-0.042-0.0200.001
put4.000.000.250.032.3781.000.00-0.075-0.0180.002
put5.000.000.100.021.4984260.00-0.115-0.0160.002
put6.000.100.200.180.9965892.00-0.285-0.0190.004
put7.500.951.250.901.4091,25317.00-0.760-0.0180.003
put9.002.152.702.301.9924.006.00-0.869-0.0170.002
put10.003.003.703.462.40086.000.00-0.929-0.0110.001
put11.004.004.704.382.6951.000.00-0.936-0.0120.001
put12.505.506.200.003.1080.000.00-0.944-0.0120.001
put14.007.007.706.553.4581.000.00-0.949-0.0130.001
put15.008.008.707.963.6641.000.00-0.951-0.0130.001
put17.5010.5011.2010.154.1120.000.00-0.956-0.0140.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-05SCHEDULE 13G/ASEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-29S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-153Initial statement of beneficial ownership of securities2026-10-09SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-06144Filing for proposed sale of securities under Rule 144.SEC
2026-10-058-KCurrent report2026-09-29SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-23144Filing for proposed sale of securities under Rule 144.SEC
2026-09-23144Filing for proposed sale of securities under Rule 144.SEC
2026-09-22144Filing for proposed sale of securities under Rule 144.SEC
2026-09-22144Filing for proposed sale of securities under Rule 144.SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-17SCHEDULE 13D/ASEC
2026-08-17SCHEDULE 13D/ASEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-14SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10001.08M3
2026-09001.20M5
2026-08999.51K122.67M6
2026-070072.38M17
2026-06001.90M3
2026-0500524.39K1
2026-04001.77M2
2026-03002.75M5
2026-02001.09M1
2026-01005.07M5
2025-125.29M58.31M13
2025-116.78M38.11M6

Institutional holders

Manager% owned
FMR LLC13.77%
BlackRock, Inc.7.20%
GLENVIEW CAPITAL MANAGEMENT, LLC5.49%
Hood River Capital Management LLC5.05%
VANGUARD CAPITAL MANAGEMENT LLC3.28%
Fosun International Ltd2.73%
D. E. Shaw & Co., Inc.2.45%
STATE STREET CORP2.21%
GEODE CAPITAL MANAGEMENT, LLC1.98%
ARK Investment Management LLC1.95%

Funds

Fund% owned
Fidelity Growth Company Fund4.13%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.26%
iShares Russell 2000 ETF2.07%
ARK Genomic Revolution ETF1.83%
Hood River New Opportunities Fund1.63%
Fidelity Growth Company K6 Fund1.19%
Fidelity Series Growth Company Fund1.01%
VANGUARD EXTENDED MARKET INDEX FUND0.94%
Fidelity Small Cap Index Fund0.88%
Nuveen Quant Small Cap Equity Fund0.78%

OakChart. BFLY. Cached 15 minutes.